Aspen Aerogels/$ASPN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aspen Aerogels
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
Ticker
$ASPN
Sector
Primary listing
NYSE
Employees
554
Headquarters
Website
Aspen Aerogels Metrics
BasicAdvanced
$700M
-
-$3.87
2.81
-
Price and volume
Market cap
$700M
Beta
2.81
52-week high
$19.22
52-week low
$4.16
Average daily volume
1.8M
Financial strength
Current ratio
3.978
Quick ratio
3.124
Long term debt to equity
44.797
Total debt to equity
56.085
Interest coverage (TTM)
2.75%
Profitability
EBITDA (TTM)
53.066
Gross margin (TTM)
36.33%
Net profit margin (TTM)
-78.53%
Operating margin (TTM)
7.74%
Effective tax rate (TTM)
-0.64%
Revenue per employee (TTM)
$720,000
Management effectiveness
Return on assets (TTM)
3.42%
Return on equity (TTM)
-75.47%
Valuation
Price to revenue (TTM)
1.724
Price to book
2.26
Price to tangible book (TTM)
2.26
Price to free cash flow (TTM)
-12.685
Free cash flow yield (TTM)
-7.88%
Free cash flow per share (TTM)
-0.67
Growth
Revenue change (TTM)
11.18%
Earnings per share change (TTM)
-20,377.90%
3-year revenue growth (CAGR)
39.63%
10-year revenue growth (CAGR)
14.01%
3-year earnings per share growth (CAGR)
24.13%
10-year earnings per share growth (CAGR)
23.69%
What the Analysts think about Aspen Aerogels
Analyst ratings (Buy, Hold, Sell) for Aspen Aerogels stock.
Bulls say / Bears say
Q2 2025 revenue of $78.0 million beat analyst expectations by 7.5%, demonstrating operational strength despite a 34% decline compared to a year ago (Nasdaq).
Adjusted EBITDA nearly doubled to $9.7 million in Q2 2025 from $4.9 million in Q1, showing the success of Aspen's cost reduction efforts and stronger operational leverage (Investing.com).
The company closed Q2 2025 with $167.6 million in cash and equivalents, ensuring a strong liquidity cushion to fund R&D and support strategy through the end of 2025 (GlobeNewswire).
Full-year 2025 guidance calls for a net loss of $307 million–$317 million and an EPS loss of $3.73–$3.86, highlighting ongoing unprofitability, mainly due to a $286.6 million impairment in Q1 2025 (Investing.com).
Revenue from the Energy Industrial segment dropped 24% quarter-over-quarter to $22.8 million in Q2 2025, pointing to weakening demand and inventory normalization risks in core industrial insulation markets (GlobeNewswire).
In March 2025, Aspen withdrew from the Department of Energy loan and canceled its Georgia plant plans, threatening its capacity expansion strategy for scaling PyroThin® production in the EV thermal barrier market (Latitude Media).
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2025.
Aspen Aerogels Financial Performance
Revenues and expenses
Aspen Aerogels Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aspen Aerogels stock?
Aspen Aerogels (ASPN) has a market cap of $700M as of October 25, 2025.
What is the P/E ratio for Aspen Aerogels stock?
The price to earnings (P/E) ratio for Aspen Aerogels (ASPN) stock is 0 as of October 25, 2025.
Does Aspen Aerogels stock pay dividends?
No, Aspen Aerogels (ASPN) stock does not pay dividends to its shareholders as of October 25, 2025.
When is the next Aspen Aerogels dividend payment date?
Aspen Aerogels (ASPN) stock does not pay dividends to its shareholders.
What is the beta indicator for Aspen Aerogels?
Aspen Aerogels (ASPN) has a beta rating of 2.81. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.